No abstract available
Keywords:
BCR-ABL; cardiovascular events; chronic phase CML; homocysteine; nilotinib.
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Cholesterol, HDL / blood
-
Coronary Artery Disease / blood
-
Coronary Artery Disease / etiology*
-
Coronary Artery Disease / pathology
-
Coronary Artery Disease / prevention & control
-
Drug Administration Schedule
-
Female
-
Homocysteine / blood
-
Humans
-
Hyperhomocysteinemia / blood
-
Hyperhomocysteinemia / complications
-
Hyperhomocysteinemia / drug therapy*
-
Hyperhomocysteinemia / pathology
-
Imatinib Mesylate / therapeutic use*
-
Leukemia, Myeloid, Chronic-Phase / blood
-
Leukemia, Myeloid, Chronic-Phase / complications
-
Leukemia, Myeloid, Chronic-Phase / drug therapy*
-
Leukemia, Myeloid, Chronic-Phase / pathology
-
Male
-
Middle Aged
-
Prospective Studies
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects*
-
Retrospective Studies
-
Triglycerides / blood
Substances
-
Antineoplastic Agents
-
Cholesterol, HDL
-
Pyrimidines
-
Triglycerides
-
Homocysteine
-
Imatinib Mesylate
-
nilotinib